4//SEC Filing
Knappertz Volker 4
Accession 0001628280-22-019950
CIK 0001600620other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:13 PM ET
Size
7.5 KB
Accession
0001628280-22-019950
Insider Transaction Report
Form 4
Knappertz Volker
EVP, Research and Development
Transactions
- Award
Stock Option (right to buy)
2022-08-01+256,892→ 256,892 totalExercise: $8.18Exp: 2032-08-01→ Common Stock (256,892 underlying) - Award
Restricted Stock Units
2022-08-01+152,812→ 152,812 total→ Common Shares (152,812 underlying)
Footnotes (2)
- [F1]One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001754122
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:13 PM ET
- Size
- 7.5 KB